Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China
· Delayed Price · Currency is CNY 41.43
-0.57 (-1.36%)
At close: Apr 30, 2025, 2:57 PM CST
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 4.65 billion as of May 6, 2025. Its market cap has decreased by -9.80% in one year.
Market Cap
4.65B
Enterprise Value
3.52B
Revenue
301.21M
Ranking
n/a
PE Ratio
298.69
Stock Price
41.43
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 4.65B, a decrease of -55.39%. That is a compound annual growth rate of -26.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 4.65B | 12.18% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 324.92B |
| Shenzhen Mindray Bio-Medical Electronics | 265.66B |
| WuXi AppTec | 168.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.88B |
| Aier Eye Hospital Group | 120.68B |
| Sichuan Biokin Pharmaceutical | 114.72B |
| Shanghai United Imaging Healthcare | 108.98B |
| Yunnan Baiyao Group Co.,Ltd | 102.18B |